Anavex Life Sciences
AVXL
#7563
Rank
NZ$0.68 B
Marketcap
NZ$7.62
Share price
-1.12%
Change (1 day)
-41.05%
Change (1 year)

Anavex Life Sciences (AVXL) - Total liabilities

Total liabilities on the balance sheet as of June 2025 : NZ$19.86 Million

According to Anavex Life Sciences 's latest financial reports the company's total liabilities are NZ$19.86 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Anavex Life Sciences - Total liabilities on balance sheet (from 2005 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-09-30NZ$24.11 M15.36%
2023-09-30NZ$20.9 M15.38%
2022-09-30NZ$18.11 M15.73%
2021-09-30NZ$15.65 M41.94%
2020-09-30NZ$11.03 M37.07%
2019-09-30NZ$8.04 M37.22%
2018-09-30NZ$5.86 M17.67%
2017-09-30NZ$4.98 M13.41%
2016-09-30NZ$4.39 M5.52%
2015-09-30NZ$4.16 M-54.58%
2014-09-30NZ$9.17 M166.29%
2013-09-30NZ$3.44 M-1.3%
2012-09-30NZ$3.48 M99.02%
2011-09-30NZ$1.75 M-60.9%
2010-09-30NZ$4.48 M-25%
2009-09-30NZ$5.97 M75.09%
2008-09-30NZ$3.41 M465.79%
2007-09-30NZ$0.6 M1306.52%
2006-09-30NZ$0.04 M9.78%
2005-09-30NZ$0.03 M948.19%
2004-09-30NZ$0 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Ligand Pharmaceuticals
LGND
NZ$0.91 B 4,489.52%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
NZ$1.44 B 7,171.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
NZ$0.33 B 1,570.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
NZ$17.51 M-11.84%๐Ÿ‡บ๐Ÿ‡ธ USA